• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

RB family functions in regulation of replication stress checkpoint

Research Project

Project/Area Number 16K07250
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Molecular biology
Research InstitutionHamamatsu University School of Medicine

Principal Investigator

UCHIDA CHIHARU  浜松医科大学, 光尖端医学教育研究センター, 准教授 (60223567)

Project Period (FY) 2016-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywords複製ストレス / RB ファミリー / RBファミリー / DNA複製ストレス / 細胞周期 / DNA損傷・修復 / ユビキチン
Outline of Final Research Achievements

High levels of DNA damage or inhibition of DNA replication by some drugs interferes with DNA replication and hamper its progression, which causes “replication stress”. Replication stress triggers cell cycle arrest to prevent cell division with abnormal genome DNA due to uncompleted DNA replication. In this study, we found that inhibition of RB family, one of the important tumor suppressor gene products, leaded to reduction in cell response against replication stress, and even delayed recovery from the replication stress. Our experimental data suggested that RB family might play an important role in activation of proper molecular signaling in cells in response to the replication stress.

Academic Significance and Societal Importance of the Research Achievements

RB は細胞老化・がん抑制に機能する。多くのがんでRBファミリーの変異や欠失が確認されており、RBファミリーの機能喪失はがん化の大きな要因とされている。複製ストレスも老化やがん化に関与することが注目されていることから、本研究成果は細胞老化・悪性化制御の研究へ発展する可能性もあり、基礎医学における普遍的な問題解明と、将来的な臨床医学への貢献の双方において重要な意義を持つことが期待される。

Report

(5 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (5 results)

All 2019 2016 Other

All Journal Article (3 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 3 results,  Open Access: 1 results) Presentation (1 results) Remarks (1 results)

  • [Journal Article] Long Noncoding RNA ELIT-1 Acts as a Smad3 Cofactor to Facilitate TGFβ/Smad Signaling and Promote Epithelial-Mesenchymal Transition.2019

    • Author(s)
      Sakai S, Ohhata T, Kitagawa K, Uchida C, Aoshima T, Niida H, Suzuki T, Inoue Y, Miyazawa K, Kitagawa M.
    • Journal Title

      Cancer Res

      Volume: 79(11) Issue: 11 Pages: 2821-38

    • DOI

      10.1158/0008-5472.can-18-3210

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Roles of pRB in the Regulation of Nucleosome and Chromatin Structures.2016

    • Author(s)
      Uchida C
    • Journal Title

      Biomed Research International

      Volume: - Pages: 1-11

    • DOI

      10.1155/2016/5959721

    • Related Report
      2016 Research-status Report
    • Peer Reviewed
  • [Journal Article] RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.2016

    • Author(s)
      Uchida C, Kitagawa M
    • Journal Title

      Curr. Cancer Drug Targets

      Volume: 16(2) Pages: 157-174

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] p130RB2は DNA複製ストレスにおける ATR活性化に正に関わる2019

    • Author(s)
      内田千晴、丹伊田 浩行、北川雅敏
    • Organizer
      第42回日本分子生物学会年会
    • Related Report
      2019 Annual Research Report
  • [Remarks] 浜松医科大学光尖端医学教育研究センター・先進機器共用推進部・先進機器研究推進室

    • URL

      http://www.equip.hama-med.ac.jp/LPAR/LPAR.html

    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi